EEF2K-VWA3A Fusion FISH Probe
The EEF2K-VWA3A Fusion FISH Probe is used to confirm a fusion of the EEF2K and VWA3A genes. The fusion of the EEF2K and VWA3A genes has been associated with Breast Invasive Carcinoma, Liver Hepatocellular Carcinoma, and Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| EEF2K-VWA3A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| EEF2K-VWA3A-20-AQAQ | 20 (40 μL) | 200 μL |
|
EEF2K Gene Summary
This gene encodes a highly conserved protein kinase in the calmodulin-mediated signaling pathway that links activation of cell surface receptors to cell division. This kinase is involved in the regulation of protein synthesis. It phosphorylates eukaryotic elongation factor 2 (EEF2) and thus inhibits the EEF2 function. The activity of this kinase is increased in many cancers and may be a valid target for anti-cancer treatment. [provided by RefSeq, Jul 2008]
Gene Name: Eukaryotic Elongation Factor 2 Kinase
Chromosome: CHR16: 22217591 -22300066
Locus: 16p12.2
VWA3A Gene Summary
The Von Willebrand Factor A Domain Containing 3A (VWA3A) gene is located on chr16 :22103862-22168287 at 16p12.2.
Gene Name: Von Willebrand Factor A Domain Containing 3A
Chromosome: CHR16: 22103862 -22168287
Locus: 16p12.2
Gene Diseases
The EEF2K VWA3A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Liver Hepatocellular Carcinoma |
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|